Helga Westerlind

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Docent in Epidemiology

PhD, Karolinska Institutet, 2014

MSc in Computer Science and Engineering from Royal Institute of Technology (KTH), 2009

PhD supervision, ongoing
Anton Öberg Sysojev (main supervisor)
Younes Laalou (main supervisor)
Liselotte Tidblad (co-supervisor)
Anna-Maria Wintler (co-supervisor)
Linnea Sjöblom (co-supervisor)

PostDoc supervision
Maxime Raffray, 2024-

Students that have defended a PhD
Weng Ian Che, 2024, co-supervisor
Joakim Lindqvist, 2022, co-supervisor

Students with a licentiate degree
Daniel Berglund, 2019, Royal Institute of Technology (KTH), co-supervisor

Artiklar

Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(6):693-701
Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis
Sysojev AO; Delcoigne B; Frisell T; Alfredsson L; Klareskog L; Saevarsdottir S; Boman M; Padyukov L; Askling J; Westerlind H
Article: RMD OPEN. 2025;11(2):e005430
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity
Tidblad L; Sysojev AO; Delcoigne B; Klareskog L; Alfredsson L; Askling J; Westerlind H; Saevarsdottir S
Article: ARTHRITIS & RHEUMATOLOGY. 2025
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis
Alm LM; Westerlind H; Gehring I; Hansson M; Ghasemzadeh N; Rojas-Restrepo J; Saevarsdottir S; Sexton J; Lillegraven S; Haavardsholm E; Glintborg B; Hammer HB; Kvien TK; Hetland ML; Padyukov L; Askling J; Gronwall C
Article: RMD OPEN. 2025;11(1):e005111
Porphyromonas gingivalis associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population
De Vries C; Circiumaru A; Mathsson-Alm L; Westerlind H; Dehara M; Kisten Y; Potempa B; Potempa J; Hensvold A; Lundberg K
Article: JOURNAL OF INTERNAL MEDICINE. 2024;296(4):336-349
Impact of cancer on the mortality of patients with idiopathic inflammatory myopathies by flexible parametric multistate modelling
Che WI; Kuja-Halkola R; Hellgren K; Lundberg IE; Westerlind H; Baecklund F; Holmqvist M
Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(9):1344-1352
Minor Genetic Overlap Among Rheumatoid Arthritis, Myocardial Infarction, and Myocardial Infarction Risk Determinants
Sysojev AO; Alfredsson L; Klareskog L; Silberberg GN; Saevarsdottir S; Padyukov L; Magnusson PKE; Askling J; Westerlind H
Article: RHEUMATOLOGY. 2024;63(5):1221-1229
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis
Sysojev AO; Saevarsdottir S; Diaz-Gallo L-M; Silberberg GN; Alfredsson L; Klareskog L; Baecklund E; Bjorkman L; Kastbom A; Rantapaa-Dahlqvist S; Turesson C; Jonsdottir I; Stefansson K; Frisell T; Padyukov L; Askling J; Westerlind H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(3):277-287
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Roennelid J
Article: RMD OPEN. 2023;9(4):e003714
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: RMD OPEN. 2023;9(3):e003027
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts
Westerlind H; Glintborg B; Hammer HB; Saevarsdottir S; Krogh NS; Hetland ML; Hauge E-M; Tejada IM; Sexton J; Askling J
Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(10):1209-1215
The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study
Boles GS; Hillert J; Ramanujam R; Westerlind H; Olsson T; Kockum I; Manouchehrinia A
Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(8):1445-1455
Familial Co-Aggregation of Idiopathic Inflammatory Myopathies and Cancer: A Swedish Population-Based Study
Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
Article: RHEUMATOLOGY. 2023;62(6):2106-2112
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Westerlind H; Kastbom A; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Gronwall C; Askling J
Article: RHEUMATOLOGY. 2023;62(3):1170-1178
Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study
Bairkdar M; Chen EY-T; Dickman PW; Hesselstrand R; Westerlind H; Holmqvist M
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):200-211
Familial autoimmunity in patients with idiopathic inflammatory myopathies
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist ME
Article: FRONTIERS IN MEDICINE. 2023;10:1146353
Molecular signature of methotrexate response among rheumatoid arthritis patients
Brynedal B; Yoosuf N; Ulfarsdottir TB; Ziemek D; Maciejewski M; Folkersen L; Westerlind H; Mueller M; Sahlstrom P; Jelinsky SA; Hensvold A; Padyukov L; Pomiano NV; Catrina A; Klareskog L; Berg L
Article: RMD OPEN. 2022;8(2):e002700
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):185
Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?
Sysojev AO; Frisell T; Delcoigne B; Saevarsdottir S; Askling J; Westerlind H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):1085-1095
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Saevarsdottir S; Stefansdottir L; Sulem P; Thorleifsson G; Ferkingstad E; Rutsdottir G; Glintborg B; Westerlind H; Grondal G; Loft IC; Sorensen SB; Lie BA; Brink M; Arlestig L; Arnthorsson AO; Baecklund E; Banasik K; Bank S; Bjorkman LI; Ellingsen T; Erikstrup C; Frei O; Gjertsson I; Gudbjartsson DF; Gudjonsson SA; Halldorsson GH; Hendricks O; Hillert J; Hogdall E; Jacobsen S; Jensen DV; Jonsson H; Kastbom A; Kockum I; Kristensen S; Kristjansdottir H; Larsen MH; Linauskas A; Hauge E-M; Loft AG; Ludviksson BR; Lund SH; Markusson T; Masson G; Melsted P; Moore KHS; Munk H; Nielsen KR; Norddahl GL; Oddsson A; Olafsdottir TA; Olason PI; Olsson T; Ostrowski SR; Horslev-Petersen K; Rognvaldsson S; Sanner H; Silberberg GN; Stefansson H; Sorensen E; Sorensen IJ; Turesson C; Bergman T; Alfredsson L; Kvien TK; Brunak S; Steinsson K; Andersen V; Andreassen OA; Rantapaa-Dahlqvist S; Hetland ML; Klareskog L; Askling J; Padyukov L; Pedersen OB; Thorsteinsdottir U; Jonsdottir I; Stefansson K
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):178
Investigation of the association between coffee and risk of RA-results from the Swedish EIRA study
Westerlind H; Dukuzimana J; Lu X; Alfredsson L; Klareskog L; Di Giuseppe D
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:514-515
THE ASSOCIATION BETWEEN AUTOANTIBODIES AND RISK FOR VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
Westerlind H; Kastbom A; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Gronwall C; Askling J
Article: ACR OPEN RHEUMATOLOGY. 2022;4(6):492-502
Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After Diagnosis
Lindqvist J; Alfredsson L; Klareskog L; Lampa J; Westerlind H
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022;53:151978
Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study
Westerlind H; Bairkdar M; Gunnarsson K; Moshtaghi-Svensson J; Sysojev AO; Hesselstrand R; Holmqvist M
Article: RMD OPEN. 2022;8(1):e002018
Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control study
Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Klareskog L; Holmqvist M; Askling J
Article: FRONTIERS IN VETERINARY SCIENCE. 2022;9:976000
Physical activity and sport-specific training patterns in Swedish sporting and working trial dogs-A questionnaire survey
Essner A; Hesbach AL; Igelstroem H; Kjellerstedt C; Svensson K; Westerlind H
Article: RMD OPEN. 2022;8(1):e001800
Sleep problems in rheumatoid arthritis over 12 years from diagnosis: results from the Swedish EIRA study
Lyne L; Akerstedt T; Alfredsson L; Lehtonen T; Saevarsdottir S; Klareskog L; Westerlind H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1461-1466
Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist M
Article: ARTHRITIS RESEARCH & THERAPY. 2021;23(1):209
Is tea consumption associated with reduction of risk of rheumatoid arthritis? A Swedish case-control study
Westerlind H; Palmqvist I; Saevarsdottir S; Alfredsson L; Klareskog L; Di Giuseppe D
Article: RHEUMATOLOGY. 2021;60(8):3760-3769
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021;39(4):879-882
Rheumatoid arthritis autoantibodies and their association with age and sex
Pertsinidou E; Manivel VA; Westerlind H; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Saevatsdottir S; Askling J; Ronnelid J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(4):271-279
Widespread non-joint pain in early rheumatoid arthritis
Schelin MEC; Westerlind H; Lindqvist J; Englid E; Israelsson L; Skillgate E; Klareskog L; Alfredsson L; Lampa J
Article: ACR OPEN RHEUMATOLOGY. 2021;3(7):457-463
What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction?
Westerlind H; Maciejewski M; Frisell T; Jelinsky SA; Ziemek D; Askling J
Article: PLOS ONE. 2021;16(4):e0250282
Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations
Diaz-Gallo L-M; Brynedal B; Westerlind H; Sandberg R; Ramskold D
Article: ARTHRITIS & RHEUMATOLOGY. 2021;73(1):61-68
Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking
Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Nyberg F; Tornling G; Klareskog L; Holmqvist M; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1658-1667
Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis
Westerlind H; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Article: GASTROENTEROLOGY. 2020;159(2):549-561.e8
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases
Stahl E; Roda G; Dobbyn A; Hu J; Zhang Z; Westerlind H; Bonfiglio F; Raj T; Torres J; Chen A; Petras R; Pardi DS; Iuga AC; Levi GS; Cao W; Jain P; Rieder F; Gordon IO; Cho JH; D'Amato M; Harpaz N; Hao K; Colombel JF; Peter I
Article: RMD OPEN. 2020;6(1):e001197
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study
Westerlind H; Delcoigne B; Askling J
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(3):616-624
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype
Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(5):683-687
Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome
Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
Article: JOURNAL OF NEUROLOGY. 2019;266(2):481-486
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
Song J; Westerlind H; McKay KA; Almqvist C; Stridh P; Kockum I; Hillert J; Manouchehrinia A
Article: ARTHRITIS CARE & RESEARCH. 2018;70(2):205-212
Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients
Lourdudoss C; Di Giuseppe D; Wolk A; Westerlind H; Klareskog L; Alfredsson L; van Vollenhoven RF; Lampa J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(14):1938-1946
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
Manouchehrinia A; Westerlind H; Kingwell E; Zhu F; Carruthers R; Ramanujam R; Ban M; Glaser A; Sawcer S; Tremlett H; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(13):1782-1785
Similar familial risk in multiple sclerosis subgroups.
Song J; Karrenbauer V; Manouchehrinia A; Almqvist C; Hillert J; Westerlind H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(9):1529-1536
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Ronnelid J
Article: GUT. 2017;66(3):421-428
Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis
Westerlind H; Mellander M-R; Bresso F; Munch A; Bonfiglio F; Assadi G; Rafter J; Huebenthal M; Lieb W; Kallberg H; Brynedal B; Padyukov L; Halfvarson J; Torkvist L; Bjork J; Andreasson A; Agreus L; Almer S; Miehlke S; Madisch A; Ohlsson B; Lofberg R; Hultcrantz R; Franke A; D'Amato M
Article: MOLECULAR MEDICINE. 2016;22:322-328
Integration of Known DNA, RNA and Protein Biomarkers Provides Prediction of Anti-TNF Response in Rheumatoid Arthritis: Results from the COMBINE Study
Folkersen L; Brynedal B; Diaz-Gallo LM; Ramskold D; Shchetynsky K; Westerlind H; Sundstrom Y; Schepis D; Hensvold A; Vivar N; Eloranta M-L; Ronnblom L; Brunak S; Malmstrom V; Catrina A; Moerch UGW; Klareskog L; Padyukov L; Berg L
Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(8):1071-1079
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study
Westerlind H; Stawiarz L; Fink K; Hillert J; Manouchehrinia A
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:146
OP0234 Rheumatoid Arthritis Subsets Defined by Sub-Specificities of Anti-Citrullinated Antibodies (ACPAS) Have Unique HLA Associations
Brynedal B; Terao C; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Skriner K; Serre G; Rönnelid J; Padyukov L; Gregersen P; Worthington J; Alfredsson L; Raychaudhuri S; Klareskog L
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2015;23(5):688-692
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort
Westerlind H; Imrell K; Ramanujam R; Myhr K-M; Celius EG; Harbo HF; Oturai AB; Hamsten A; Alfredsson L; Olsson T; Kockum I; Koski T; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(12):1578-1583
New data identify an increasing sex ratio of multiple sclerosis in Sweden
Westerlind H; Bostrom I; Stawiarz L; Landtblom A-M; Almqvist C; Hillert J
Article: BRAIN. 2014;137(Pt 3):770-778
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden
Westerlind H; Ramanujam R; Uvehag D; Kuja-Halkola R; Boman M; Bottai M; Lichtenstein P; Hillert J
Article: NATURE GENETICS. 2013;45(11):1353-1360
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Beecham AH; Patsopoulos NA; Xifara DK; Davis MF; Kemppinen A; Cotsapas C; Shah TS; Spencer C; Booth D; Goris A; Oturai A; Saarela J; Fontaine B; Hemmer B; Martin C; Zipp F; D'Alfonso S; Martinelli-Boneschi F; Taylor B; Harbo HF; Kockum I; Hillert J; Olsson T; Ban M; Oksenberg JR; Hintzen R; Barcellos LF; Agliardi C; Alfredsson L; Alizadeh M; Anderson C; Andrews R; Sondergaard HB; Baker A; Band G; Baranzini SE; Barizzone N; Barrett J; Bellenguez C; Bergamaschi L; Bernardinelli L; Berthele A; Biberacher V; Binder TMC; Blackburn H; Bomfim IL; Brambilla P; Broadley S; Brochet B; Brundin L; Buck D; Butzkueven H; Caillier SJ; Camu W; Carpentier W; Cavalla P; Celius EG; Coman I; Comi G; Corrado L; Cosemans L; Cournu-Rebeix I; Cree BAC; Cusi D; Damotte V; Defer G; Delgado SR; Deloukas P; di Sapio A; Dilthey AT; Donnelly P; Dubois B; Duddy M; Edkins S; Elovaara I; Esposito F; Evangelou N; Fiddes B; Field J; Franke A; Freeman C; Frohlich IY; Galimberti D; Gieger C; Gourraud P-A; Graetz C; Graham A; Grummel V; Guaschino C; Hadjixenofontos A; Hakonarson H; Halfpenny C; Hall G; Hall P; Hamsten A; Harley J; Harrower T; Hawkins C; Hellenthal G; Hillier C; Hobart J; Hoshi M; Hunt SE; Jagodic M; Jelcic I; Jochim A; Kendall B; Kermode A; Kilpatrick T; Koivisto K; Konidari I; Korn T; Kronsbein H; Langford C; Larsson M; Lathrop M; Lebrun-Frenay C; Lechner-Scott J; Lee MH; Leone MA; Leppa V; Liberatore G; Lie BA; Lill CM; Linden M; Link J; Luessi F; Lycke J; Macciardi F; Mannisto S; Manrique CP; Martin R; Martinelli V; Mason D; Mazibrada G; McCabe C; Mero I-L; Mescheriakova J; Moutsianas L; Myhr K-M; Nagels G; Nicholas R; Nilsson P; Piehl F; Pirinen M; Price SE; Quach H; Reunanen M; Robberecht W; Robertson NP; Rodegher M; Rog D; Salvetti M; Schnetz-Boutaud NC; Sellebjerg F; Selter RC; Schaefer C; Shaunak S; Shen L; Shields S; Siffrin V; Slee M; Sorensen PS; Sorosina M; Sospedra M; Spurkland A; Strange A; Sundqvist E; Thijs V; Thorpe J; Ticca A; Tienari P; van Duijn C; Visser EM; Vucic S; Westerlind H; Wiley JS; Wilkins A; Wilson JF; Winkelmann J; Zajicek J; Zindler E; Haines JL; Pericak-Vance MA; Ivinson AJ; Stewart G; Hafler D; Hauser SL; Compston A; McVean G; De Jager P; Sawcer SJ; McCauley JL
Article: MULTIPLE SCLEROSIS JOURNAL. 2012;18(12):1775-1781
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice
Jungedal R; Lundkvist M; Engdahl E; Ramanujam R; Westerlind H; Sominanda A; Hillert J; Fogdell-Hahn A
Article: PLOS ONE. 2012;7(5):e36779
Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis
Link J; Kockum I; Lorentzen AR; Lie BA; Celius EG; Westerlind H; Schaffer M; Alfredsson L; Olsson T; Brynedal B; Harbo HF; Hillert J
Article: JOURNAL OF NEUROIMMUNOLOGY. 2011;237(1-2):98-100
No influence on disease progression of non-HLA susceptibility genes in MS
Lundstrom W; Greiner E; Lundmark F; Westerlind H; Smestad C; Lorentzen AR; Kockum I; Link J; Brynedal B; Celius EG; Harbo HF; Masterman T; Hillert J
Visa fler

Alla övriga publikationer

Editorial comment: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2024;52(8):1019-1025
Legal obstacles jeopardise research in personalised medicine - experiences from a Nordic collaboration within rheumatology
Glintborg B; Hansson M; Hammer HB; Klareskog L; Saevarsdottir S; Westerlind H; Ronnelid J; Gehring I; Benson M; Esbensen BA; Hetland ML; Padyukov L; Kragstrup TW; Hauge E-M; Axnas BB; Krogh NS; Johannesson M; Askling J
Corrigendum: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;63:152311
Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study (vol 53, 151978, 2022)
Westerlind H; Bairkdar M; Gunnarsson K; Moshtaghi-Svensson J; Sysojev AO; Hesselstrand R; Holmqvist M
Letter: RHEUMATOLOGY. 2023;62(6):e204
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply
Westerlind H; Kastbom A; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1297
AB0225 WHAT FACTORS INFLUENCE RA PRESENTATION AT DIAGNOSIS?
Di Giuseppe D; Askling J; Westerlind H
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:222-223
DO COMORBIDITIES INCREASE THE RISK OF FAILURE TO REACH REMISSION IN EARLY RHEUMATOID ARTHRITIS PATIENTS RECEIVING METHOTREXATE AS FIRST-LINE THERAPY?
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52:20-21
Legal obstacles jeopardize research in personalised medicine - experiences from a Nordic collaboration within rheumatology
Glintborg B; Hansson M; Hammer HB; Klareskog L; Saevarsdottir S; Westerlind H; Ronnelid J; Gehring I; Benson M; Esbensen BA; Hetland ML; Padyukov L; Kragstrup TW; Hauge E; Axnas BB; Krogh NS; Johannesson M; Askling J
Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):415-416
FAMILIAL ASSOCIATIONS OF AUTOIMMUNE DISEASES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES - A SWEDISH POPULATION-BASED STUDY
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist M
Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):435
CLUSTERING OF CANCERS IN FAMILIES OF IDIOPATHIC INFLAMMATORY MYOPATHIES: ASSOCIATIONS VARY BY CLINICAL PHENOTYPE AND SEX
Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:178
A GENOME-WIDE INVESTIGATION OF PERSISTENCE TO TREATMENT WITH METHOTREXATE IN SWEDISH EARLY RHEUMATOID ARTHRITIS PATIENTS
Sysojev AO; Saevarsdottir S; Diaz-Gallo LM; Alfredsson L; Klareskog L; Frisell T; Padyukov L; Askling J; Westerlind H
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:2265-2269
GWAS Identified New Genes in Synovial Fibroblasts Linked to Early Remission in RA
Maurits M; Abasolo Alcazar L; van den Akker E; Askling J; Barton A; Bluml S; Bohringer S; Cope A; Emery P; Eyre S; Gaddi P; Gonzalez I; Goodyear C; van der Helm-van Mil A; Hu X; Huizinga T; Isaacs JD; Jelinsky S; Johannesson M; Zapata SJ; Ke C; Klareskog L; Lendrem D; Lewis M; Liu M; Martin P; McInnes IB; Micheroli R; Morgan A; Morton F; Naamane N; Orozco G; Ospelt C; Padyukov L; Paterson C; Plant D; Porter D; Pratt A; Raychaudhuri S; Reynard L; Rodriguez-Rodriguez L; Sieghart D; Studenic P; Taylor J; Toes R; Verstappen M; Verstappen S; Westerlind H; Winkler A; Knevel R
Review: RHEUMATOLOGY. 2021;60(7):3121-3133
Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis
Bairkdar M; Rossides M; Westerlind H; Hesselstrand R; Arkema EV; Holmqvist M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:1059-1060
IS TEA CONSUMPTION ASSOCIATED WITH RISK OF RHEUMATOID ARTHRITIS?
Westerlind H; Palmqvist I; Saevarsdottir S; Alfredsson L; Klareskog L; Di Giuseppe D
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:256
Familial co-aggregation of idiopathic inflammatory myopathies and cancers
Che WI; Baecklund F; Hellgren K; Halkola RK; Lundberg IE; Westerlind H; Holmqvist M
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:81-82
Systemic sclerosis mortality in Sweden: a population-based matched cohort study
Bairkdar M; Chen EYT; Dickman PW; Hesselstrand R; Westerlind H; Holmqvist M
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:78-79
Familial coaggregation of idiopathic inflammatory myopathies and other autoimmune diseases
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kujahalkola R; Holmqvist M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):48
Similar familial risk and heritability in relapsing and progressive onset multiple sclerosis
Manouchehrinia A; Boles GS; Hillert J; Westerlind H; Olsson T; Kockum I
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:614
SLEEP PROBLEMS IN EARLY RHEUMATOID ARTHRITIS
Lehtonen T; Akerstedr T; Lyne L; Klareskog L; Saevarsdottir S; Alfredsson L; Westerlind H
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:271-272
COMORBIDITIES AT DIAGNOSIS OF RHEUMATOID ARTHRITIS
Tidblad L; Westerlind H; Askling J; Saevarsdottir S
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):e50
Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu
Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
Corrigendum: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(4):880
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype (vol 105, pg 616, 2019)
Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
Preprint: BIORXIV. 2019
Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations
Diaz-Gallo L-M; Brynedal B; Westerlind H; Sandberg R; Ramsköld D
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:301
IN EARLY RHEUMATOID ARTHRITIS ANTI-CITRULLINATED PEPTIDE ANTIBODIES ASSOCIATE WITH LOWER NUMBER OF AFFECTED JOINTS, AND IGM RHEUMATOID FACTOR WITH SYSTEMIC INFLAMMATION IN AN ANTI-CITRULLINE DEPENDENT MANNER
Pertsinidou E; Manivel VA; Klareskog L; Alfredsson L; Mathsson L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Saevarsdottir S; Ronnelid J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:697
ANTI-CITRULLINATED PROTEIN ANTIBODY SPECIFICITIES, RHEUMATOID FACTOR ISOTYPES AND RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS
Westerlind H; Ronnelid J; Hansson M; Alfredsson L; Mathsson L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:2104
IGA RF IS ASSOCIATED WITH HIGH AGE OF RHEUMATOID ARTHRITIS ONSET
Pertsinidou E; Klareskog L; Alfredsson L; Mathsson L; Hansson M; Westerlind H; Askling J; Saevarsdottir S; Ronnelid J
Letter: ARTHRITIS & RHEUMATOLOGY. 2018;70(12):2096-2097
Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al
Derksen VFAM; Westerlind H; Saevarsdottir S; Ajeganova S; Trouw LA; Huizinga TWJ; van der Helm-van Mil AHM; Knevel R; van der Woude D
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:119
SIBLINGS OF PATIENTS WITH RHEUMATOID ARTHRITIS ARE AT INCREASED RISK OF ACUTE CORONARY SYNDROME
Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70
Predictors of Persistence to Methotrexate Treatment in RA - Assessment of Different Modelling Approaches
Westerlind H; Maciejewski M; Frisell T; Jelinsky S; Ziemek D; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:1038
SUBGROUPING OF EARLY RA-PATIENTS IDENTIFIED CLUSTER OF PATIENTS WITH HIGH LEVELS OF PAIN, FATIGUE AND PSYCHOSOCIAL DISTRESS 3 YEARS AFTER DIAGNOSIS
Lindqvist J; Westerlind H; Klareskog L; Alfredsson L; Lampa J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:1037
PREDICTORS AND PERSISTENCE OF UNACCEPTABLE PAIN DURING THE FIRST YEAR OF RHEUMATOID ARTHRITIS IN SWEDEN
Westerlind H; Schelin ME; Altawil R; Klareskog L; Alfredsson L; Lampa J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:228
ANTI-COLLAGEN TYPE II ANTIBODIES ARE ASSOCIATED WITH AN ACUTE ONSET RHEUMATOID ARTHRITIS PHENOTYPE AND PROGNOSTICATE LOWER DEGREE OF INFLAMMATION
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Ronnelid J
Letter: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2):305-307
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?
Westerlind H; Stawiarz L; Fink K; Hillert J; Manouchehrinia A
Letter: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016;111(8):1211-1213
HLA Associations Distinguish Collagenous From Lymphocytic Colitis
Westerlind H; Bonfiglio F; Mellander M-R; Huebenthal M; Brynedal B; Bjork J; Torkvist L; Padyukov L; Ohlsson B; Lofberg R; Hultcrantz R; Franke A; Bresso F; D'Amato M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:411
OMEGA-3 FATTY ACIDS ASSOCIATES WITH DECREASED PAIN, INDEPENDENT OF INFLAMMATION, IN MTX TREATED EARLY RA PATIENTS
Lourdudoss C; Wolk A; Di Giuseppe D; Westerlind H; Klareskog L; Alfredsson L; van Vollenhoven R; Lampa J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:174
NO LONG-TERM EFFECT ON DISEASE ACTIVITY AND PAIN OF PHYSICAL ACTIVITY FOUND IN PROSPECTIVE OBSERVATIONAL STUDY OF EARLY RHEUMATOID ARTHRITIS
Sandberg ME; Westerlind H; Saevarsdottir S; Frumento P; Klareskog L; Alfredsson L
Conference publication: NEUROLOGY. 2016;86
Age Related Multiple Sclerosis Severity Score: Disability Ranked by Age
Manouchehrinia A; Helga W; Kingwell E; Zhu F; Carruthers R; Ujam RR; Maria B; Glaser A; Sawcer S; Tremlett H; Hillert J
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68
Specific Antibody Subphenotypes in Rheumatoid Arthritis Are Associated with Unique HLA-DRB1 Residues at Position 11
Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Mathsson-Alm L; Jakobsson PJ; Skriner K; Serre G; Ronnelid J; Padyukov L; Worthington J; Alfredsson L; Klareskog L; Raychaudhuri S
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68
Antibody Mediated Immunity Drives Response to Methotrexate Treatment in Rheumatoid Arthritis Patients
Brynedal B; Westerlind H; Folkersen L; Padyukov L; Vivar N; Catrina AI; Klareskog L; Berg L
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:174
Familial risk of childhood- versus late-onset multiple sclerosis: a nation-wide cohort study
Song J; Westerlind H; Almqvist C; Hillert J; Manouchehrinia A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:56
A significant decrease in the diagnosis of primary progressive multiple sclerosis: a cohort study
Westerlind H; Stawiarz L; Fink K; Hillert J; Manouchehrinia A
Letter: BRAIN. 2014;137(Pt 7):e288
Reply: Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies
Westerlind H; Kuja-Halkola R; Ramanujam R; Hillert J
Doctoral thesis: 2014
Modeling genetic susceptibility to multiple sclerosis
Westerlind H
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):12-13
Modest familial risks for multiple sclerosis: a population-based registry study of Sweden
Westerlind H; Ramanujam R; Uvehag D; Kuja-Halkola R; Boman M; Lichtenstein P; Hillert J
Conference publication: JOURNAL OF NEUROLOGY. 2011;258:264
How do patients with neutralising antibodies to recombinant interferon-β treatment develop in their clinical outcome?
Fink K; Westerlind H; Lundkvist M; Fogdell-Hahn A; Hillert J
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2011;73(4):369-370
Clinical Outcomes in Patients with Multiple Sclerosis who Develop Neutralizing Antibodies to Recombinant Interferon-Beta Treatment
Fink K; Westerlind H; Lundkvist M; Fogdell-Hahn A; Hillert J
Visa fler

Forskningsbidrag

Precision prevention and early therapy for RA; Combining patient reported information, epidemiology, genetics and immunology
Swedish Research Council
1 January 2024 - 31 December 2026
Proteogenomics to identify sarcoidosis biomarkers and endotypes
Swedish Research Council
1 January 2023 - 31 December 2025
Personalized prevention and therapy for RA; Combining patient reported information, epidemiology, genetics and immunology
Swedish Research Council
1 January 2021 - 31 December 2023

Anställningar

Senior Forskningsspecialist, Medicin, Solna, Karolinska Institutet, 2022-

Examina och utbildning

Docent, Epidemiologi, Karolinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2014

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI